The management of cirrhotic ascites

Hepatology

Volumn 50, Issue 4, 2009, Pages 1320-

  Lo, Gin Ho ^a  

^a I SHOU UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; LAMIVUDINE; MIDODRINE; OCTREOTIDE; TERLIPRESSIN; VASOACTIVE AGENT; ANTIVIRUS AGENT;

ALCOHOL CONSUMPTION; ALCOHOLISM; ANTIVIRAL THERAPY; ASCITES; CLINICAL TRIAL; DRUG EFFICACY; DRUG INFUSION; HEPATITIS B; HEPATORENAL SYNDROME; HUMAN; KIDNEY FUNCTION; LETTER; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; HEPATITIS B VIRUS; LIVER CELL CARCINOMA; LIVER TUMOR; NOTE; PATHOGENICITY; VIROLOGY;

ANTIVIRAL AGENTS; ASCITES; CARCINOMA, HEPATOCELLULAR; HEPATITIS B; HEPATITIS B VIRUS; HUMANS; LAMIVUDINE; LIVER NEOPLASMS; LIVER TRANSPLANTATION; PRACTICE GUIDELINES AS TOPIC;

EID: 70350046662     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.23140     Document Type: Letter

References (5)

1. Runyon BA. Management of adult patients with ascites due to cirrhosis: an update. HEPATOLOGY 2009;49:2087-2107.
2. Villeneuve JP, Condreay LD, Williams B, Pomier-Layrarques G, Fenyves D, Bilodeau M, et al. lamivudine treatment for decompensated cirrhosis resulting from chronic hepatitis B. HEPATOLOGY 2000;31:207-210.
3. Kapoor D, Guptan RC, Wakil SM, Kazim SN, Kaul R, Agarwal SR, et al. Beneficial effects of lamivudine in hepatitis B virus-related decompensated cirrhosis. J Hepatol 2000;33:308-312.
4. Sanyal A, Boyer T, Garcia-Tsao G, Regenstein F, Rossaro L, Appenrodt B, et al. A prospective, randomized, double-blind, placebo-controlled trial of terlipressin for type 1 hepatorenal syndrome (HRS). Gastroenterology 2008;134:1360-1368.
5. Fabrizi F, Dixit V, Martin P. Meta-analysis: terlipressin therapy for hepatorenal syndrome. Aliment Pharmacol Ther 2006;24:935-944.